ZNTL biotech catalysts & pipeline

ZENTALIS PHARMACEUTICALS INC · Data as of 2026-10-25

Upcoming catalysts

Late 2026

We expect to complete enrollment in all cohorts of DENALI Part 2 and provide a topline readout of the trial by year-end 2026.

1H 2027

DENALI Part 2 topline readout expected in 1H 2027 to allow for data maturation post full enrollment